Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
Pd
Molecular Weight:
106.42
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
11101718
MDL number:
Quality Level
form
(wet)
contains
≤50% water
reaction suitability
core: palladium, reaction type: Buchwald-Hartwig Cross Coupling Reaction, reaction type: Heck Reaction, reaction type: Hiyama Coupling, reaction type: Negishi Coupling, reaction type: Sonogashira Coupling, reaction type: Stille Coupling, reaction type: Suzuki-Miyaura Coupling, reagent type: catalyst
extent of labeling
5 wt. % loading (dry basis)
weight
Unit weight excludes weight of water
matrix
activated carbon, wet support
SMILES string
[Pd]
InChI
1S/Pd
InChI key
KDLHZDBZIXYQEI-UHFFFAOYSA-N
Application
Catalyst for:
- Stille reaction
- Hydrogenation reactions
- Suzuki-Miyaura cross-coupling and Heck-Mizoroki reactions
- Deoxygenation
- Oxidation reactions
- Coupling reactions
signalword
Danger
hcodes
Hazard Classifications
Flam. Sol. 1
Storage Class
4.1B - Flammable solid hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Carmen Abate et al.
ChemMedChem, 6(1), 73-80 (2010-11-12)
Many new chemotherapeutic agents are under preclinical investigation and, despite efforts to more selectively target cancer cells, limitations such as toxicity and inherent resistance are often encountered. Therefore, alternative strategies are needed to treat cancer and overcome such limitations. We
Carmen Abate et al.
Journal of medicinal chemistry, 57(8), 3314-3323 (2014-04-05)
Despite the promising potentials of σ2 receptors in cancer therapy and diagnosis, there are still ambiguities related to the nature and physiological role of the σ2 protein. With the aim of providing potent and reliable tools to be used in
Carmen Abate et al.
ChemMedChem, 7(10), 1847-1857 (2012-08-15)
σ(2) Receptor research is receiving increasing interest with regard to the potential of σ(2) proteins as targets for tumor therapy and diagnosis. Nevertheless, knowledge about the σ(2) receptor is far from conclusive. The paucity and modest affinity of known σ(2)
